Partners Sabrina Wang and David Schmidt will be participating in programming at the upcoming LSI Asia Emerging Medtech Summit. On July 1, Sabrina and David will lead the workshop “Is AI Ready to own Your FTO? IP Due Diligence in the Era of Generative AI.” On July 2, David will join professionals from Inari Medical, Profusa, and Medtronic in discussing “Exit Pathways in the East: Positioning Your Medtech for Strategic Acquisition vs IPO.” LSI Asia brings together leaders across the global life sciences and medtech industry.
No CLE credit available for attorneys
Location
Shangri-La Orchard Rd.
22 Orange Grove Rd.
Singapore, 258350
Singapore, 258350
